﻿<?xml version="1.0" encoding="UTF-8" ?>
<rdf:RDF xmlns:admin="http://webns.net/mvcb/" xmlns="http://purl.org/rss/1.0/" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:prism="http://purl.org/rss/1.0/modules/prism/" xmlns:taxo="http://purl.org/rss/1.0/modules/taxonomy/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:syn="http://purl.org/rss/1.0/modules/syndication/">
<channel rdf:about="http://medrxiv.org">
<admin:errorReportsTo rdf:resource="mailto:medrxiv@cshlpress.edu"/>
<title>medrxiv Subject Collection: Psychiatry And Clinical Psychology</title>
<link>http://medrxiv.org</link>
<description>
This feed contains articles for medRxiv Subject Collection "Psychiatry And Clinical Psychology"
</description>

<items>
<rdf:Seq>
<rdf:li rdf:resource="https://www.medrxiv.org/content/10.64898/2026.06.15.26355706v1?rss=1"/>
<rdf:li rdf:resource="https://www.medrxiv.org/content/10.64898/2026.06.24.26356429v1?rss=1"/>
<rdf:li rdf:resource="https://www.medrxiv.org/content/10.64898/2026.06.24.26354566v1?rss=1"/>
<rdf:li rdf:resource="https://www.medrxiv.org/content/10.64898/2026.06.23.26356303v1?rss=1"/>
<rdf:li rdf:resource="https://www.medrxiv.org/content/10.64898/2026.06.23.26356366v1?rss=1"/>
<rdf:li rdf:resource="https://www.medrxiv.org/content/10.64898/2026.06.23.26356304v1?rss=1"/>
<rdf:li rdf:resource="https://www.medrxiv.org/content/10.64898/2026.06.15.26355458v1?rss=1"/>
<rdf:li rdf:resource="https://www.medrxiv.org/content/10.64898/2026.06.22.26356249v1?rss=1"/>
<rdf:li rdf:resource="https://www.medrxiv.org/content/10.64898/2026.06.15.26355692v1?rss=1"/>
<rdf:li rdf:resource="https://www.medrxiv.org/content/10.64898/2026.06.22.26356085v1?rss=1"/>
<rdf:li rdf:resource="https://www.medrxiv.org/content/10.64898/2026.06.21.26356195v1?rss=1"/>
<rdf:li rdf:resource="https://www.medrxiv.org/content/10.64898/2026.06.22.26356231v1?rss=1"/>
<rdf:li rdf:resource="https://www.medrxiv.org/content/10.64898/2026.06.21.26356048v1?rss=1"/>
<rdf:li rdf:resource="https://www.medrxiv.org/content/10.64898/2026.06.21.26356164v1?rss=1"/>
<rdf:li rdf:resource="https://www.medrxiv.org/content/10.64898/2026.06.20.26356092v1?rss=1"/>
<rdf:li rdf:resource="https://www.medrxiv.org/content/10.64898/2026.06.12.26355506v1?rss=1"/>
<rdf:li rdf:resource="https://www.medrxiv.org/content/10.64898/2026.06.18.26355841v1?rss=1"/>
<rdf:li rdf:resource="https://www.medrxiv.org/content/10.64898/2026.06.18.26355974v1?rss=1"/>
<rdf:li rdf:resource="https://www.medrxiv.org/content/10.64898/2026.06.18.26355956v1?rss=1"/>
<rdf:li rdf:resource="https://www.medrxiv.org/content/10.64898/2026.06.19.26356081v1?rss=1"/>
<rdf:li rdf:resource="https://www.medrxiv.org/content/10.64898/2026.06.18.26355880v1?rss=1"/>
<rdf:li rdf:resource="https://www.medrxiv.org/content/10.64898/2026.06.17.26354096v1?rss=1"/>
<rdf:li rdf:resource="https://www.medrxiv.org/content/10.64898/2026.06.11.26355007v1?rss=1"/>
<rdf:li rdf:resource="https://www.medrxiv.org/content/10.64898/2026.06.17.26355864v1?rss=1"/>
<rdf:li rdf:resource="https://www.medrxiv.org/content/10.64898/2026.06.16.26355798v1?rss=1"/>
<rdf:li rdf:resource="https://www.medrxiv.org/content/10.64898/2026.06.16.26355796v1?rss=1"/>
<rdf:li rdf:resource="https://www.medrxiv.org/content/10.64898/2026.06.12.26355405v1?rss=1"/>
<rdf:li rdf:resource="https://www.medrxiv.org/content/10.64898/2026.06.16.26355784v1?rss=1"/>
<rdf:li rdf:resource="https://www.medrxiv.org/content/10.64898/2026.06.09.26354804v1?rss=1"/>
<rdf:li rdf:resource="https://www.medrxiv.org/content/10.64898/2026.06.09.26355019v1?rss=1"/>
</rdf:Seq>
</items>
<prism:eIssn/>
<prism:publicationName>medrxiv</prism:publicationName>
<prism:issn/>

<image rdf:resource=""/>
</channel>
<image rdf:about="">
<title>medrxiv</title>
<url>https://www.medrxiv.org/sites/default/files/medrxiv_internal_logo.png</url>
<link>http://medrxiv.org</link>
</image>
<item rdf:about="https://www.medrxiv.org/content/10.64898/2026.06.15.26355706v1?rss=1">
<title>
<![CDATA[
Aging-Related lncRNA Expression in Bipolar Disorder: Effects of Familial Liability and Childhood Trauma 
]]>
</title>
<link>
https://www.medrxiv.org/content/10.64898/2026.06.15.26355706v1?rss=1
</link>
<description><![CDATA[
Introduction: Bipolar disorder (BD) has been associated with increased medical burden and accelerated biological aging. Long non-coding RNAs (lncRNAs) regulate molecular pathways related to cellular senescence, inflammation, and telomere maintenance, which are implicated in both BD and aging. This study examined whether aging-related lncRNA expression reflects familial vulnerability or illness-specific effects, and whether childhood trauma and lifestyle factors modulate these signatures within a gene-environment framework. Methods: In this cross-sectional study, expression levels of aging-related lncRNAs, including Antisense Non-coding RNA in the INK4 Locus (ANRIL), HOX Transcript Antisense Intergenic RNA (HOTAIR), Nuclear Enriched Abundant Transcript 1 (NEAT1), Taurine Upregulated Gene 1 (TUG1), Metastasis-Associated Lung Adenocarcinoma Transcript 1 (MALAT1), Growth Arrest-Specific 5 (GAS5), and Telomerase RNA Component (TERC), were measured in peripheral blood mononuclear cells (PBMCs) from individuals with bipolar disorder (BD) (n=68), siblings without BD diagnosis (SIB) (n=54), and healthy controls (HC) (n=70) using quantitative reverse transcription polymerase chain reaction (RT-qPCR). Childhood trauma and lifestyle were assessed using the Childhood Trauma Questionnaire (CTQ) and the Healthy Lifestyle Profile II (HPLP-II). Principal component analysis generated a composite aging-related lncRNA factor. Results: At the individual transcript level, NEAT1 and TERC were elevated, whereas GAS5 was reduced, in both BD and SIB relative to HC. The aging-related lncRNA composite score was higher in BD and SIB than in HC (F = 7.315, p = 0.001). Familial liability to BD (presence vs. absence of familial liability) showed a significant main effect on the composite score (F(1,182)=8.18, p=0.005) and interacted with childhood trauma (F(1,182)=10.14, p=0.002). In multivariable models, total CTQ and physical neglect were independently associated with lower composite scores, while familial liability remained a positive predictor (all p<0.001). Conclusions: Aging-related lncRNA alterations mark familial vulnerability to BD and are shaped by childhood trauma within a gene-environment interaction framework.
]]></description>
<dc:creator><![CDATA[ Ekinci, S., Yesiloglu, B., Fettahoglu, I., Pamukcu Unlu, C., Arat Celik, H. E., Hun Senol, S., Balac, S., Corekli Kaymakci, E., Kok Kendirlioglu, B., Frye, M. A., Ozerdem, A., Altintas, M., Ceylan, D. ]]></dc:creator>
<dc:date>2026-06-26</dc:date>
<dc:identifier>doi:10.64898/2026.06.15.26355706</dc:identifier>
<dc:title><![CDATA[Aging-Related lncRNA Expression in Bipolar Disorder: Effects of Familial Liability and Childhood Trauma]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory</dc:publisher>
<prism:publicationDate>2026-06-26</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://www.medrxiv.org/content/10.64898/2026.06.24.26356429v1?rss=1">
<title>
<![CDATA[
Brain and vascular integrity related to cognitive and motor flexibility in autism: a study protocol 
]]>
</title>
<link>
https://www.medrxiv.org/content/10.64898/2026.06.24.26356429v1?rss=1
</link>
<description><![CDATA[
Introduction: Autism spectrum disorder, or autism, is a common neurodevelopmental condition characterized by socio-communicative problems together with restrictive and repetitive behaviors. Typically, the latter is manifested as deficits in behavioral flexibility, i.e. changing routine behaviors to adapt to environmental changes. Despite noticeable difficulties with flexible behavior in autism, there is to date not adequate knowledge about the intricacies of such challenges and neurobiological processes that may subserve them. This study aims to investigate both cognitive and motor flexibility in autistic compared with neurotypical adults using a novel combination of detailed methods for brain imaging and behavioral investigations in relation to probabilistic reversal learning (PRL) paradigms. In addition, the experiences of autistic adults on flexible behavior in education and everyday activities will be explored. Methods and analysis: Differences in cognitive flexibility between autistic (n[&ge;]20) and neurotypical (n[&ge;]20) adults (18-35 years) will be investigated in terms of brain activations, measured by functional magnetic resonance imaging (fMRI), during two-choice PRL performance (cognitive task). In addition, group differences in microcirculation as measured by arterial spin labelling (ASL) will be evaluated. Group differences in motor flexibility will be investigated as expressed in movement planning and execution (spatio-temporal parameters), measured by a robotic manipulandum platform (KinArm End-Point Robot), during two-choice PRL performance (motor task). Semi-structured interviews will be conducted individually with autistic participants (n=15). Questions concern own experiences of cognitive and motor behavior, and strategies used to support flexibility in these behaviors. Data from this qualitative approach will be analyzed by thematic analysis. Ethics and dissemination: Ethical approval has been obtained from the Swedish Ethical Review Authority (ref:2025-07939-01) and the study will be conducted in accordance with the Declaration of Helsinki, the European Union General Data Protection Regulation (GDPR) and national guidelines for the storing of personal data. The different investigations included are well-established, non-invasive and safe. Study outcomes will be published in peer-reviewed international scientific journals (open access), presented at national and international conferences, and to any interested audience/stakeholders.
]]></description>
<dc:creator><![CDATA[ Domellof, E., Johansson, A., Stillesjo, S., Karlsson Wirebring, L., Wiklund Hornqvist, C., Johansson, A.-M., Rudolfsson, T., Wahlin, A., Wadenholt, G., Ekesryd Nordstrom, M., Safstrom, D. ]]></dc:creator>
<dc:date>2026-06-26</dc:date>
<dc:identifier>doi:10.64898/2026.06.24.26356429</dc:identifier>
<dc:title><![CDATA[Brain and vascular integrity related to cognitive and motor flexibility in autism: a study protocol]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory</dc:publisher>
<prism:publicationDate>2026-06-26</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://www.medrxiv.org/content/10.64898/2026.06.24.26354566v1?rss=1">
<title>
<![CDATA[
The lasting impact of NICU admission on the parents of children with non-cardiac congenital anomalies: trauma, mental health, and unmet support needs 5-16 years following discharge 
]]>
</title>
<link>
https://www.medrxiv.org/content/10.64898/2026.06.24.26354566v1?rss=1
</link>
<description><![CDATA[
Background Despite growing evidence that interventions targeting parental distress are associated with improved outcomes in families of children with life-threatening conditions, mental health research is limited for parents of NICU graduates treated for non-cardiac congenital anomalies. Aims To examine the prevalence and severity of mental health difficulties and post-traumatic stress, including subthreshold trauma-related distress, in these parents. Method Participants were 103 parents (n=86 female) of children, aged 5-16 years, who were treated in the NICU for non-cardiac congenital anomalies (e.g., congenital diaphragmatic hernia [CDH], tracheo-oesophageal fistula and/or oesophageal atresia [TOF-OA], abdominal wall defects) at a large tertiary-level paediatric hospital in Australia. Validated measures of mental health (DASS-21) and post-traumatic stress (PCL-5) were administered using an online cross-sectional survey. Whole group and diagnostic subgroup scores were compared with normative data. Comparisons between parents of primary school and high school-aged children enabled the examination of differences in unmet support needs according to their child's developmental stage. Results Seventy-four percent of parents reported experiencing mental health difficulties since their child's congenital anomaly diagnosis, yet only 44.7% had accessed professional mental health support. The mean DASS-21 'Stress' score was significantly elevated relative to Australian population norms (p<0.0005). Scores on the PCL-5 indicated that 9.4% met DSM-5 criteria for provisional PTSD diagnoses and a further 20.8% met subthreshold PTSD criteria. Importantly, 50% of parents reporting subthreshold PTSD had not accessed professional psychological support. Mental health concerns appeared more prominent among parents of children with TOF-OA and CDH, as well as parents of high school-aged children. Conclusions Parents report elevated stress and clinically meaningful subthreshold PTSD symptoms long after their child's NICU discharge, yet many do not access formal support. These findings highlight the importance of trauma-informed approaches to ongoing mental health surveillance and support for parents of NICU graduates with non-cardiac congenital anomalies.
]]></description>
<dc:creator><![CDATA[ Wilkie, L. J., Malarbi, S., Ryan, N. P., Wood, A. G. ]]></dc:creator>
<dc:date>2026-06-26</dc:date>
<dc:identifier>doi:10.64898/2026.06.24.26354566</dc:identifier>
<dc:title><![CDATA[The lasting impact of NICU admission on the parents of children with non-cardiac congenital anomalies: trauma, mental health, and unmet support needs 5-16 years following discharge]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory</dc:publisher>
<prism:publicationDate>2026-06-26</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://www.medrxiv.org/content/10.64898/2026.06.23.26356303v1?rss=1">
<title>
<![CDATA[
Regional variation and urban-rural differences in partner similarity: a nationwide cohort study 
]]>
</title>
<link>
https://www.medrxiv.org/content/10.64898/2026.06.23.26356303v1?rss=1
</link>
<description><![CDATA[
Although romantic partners tend to resemble each other on many characteristics, the geographical processes underlying partner similarities remain poorly understood. Using Finnish nationwide registry data from cohabiting or married partners (N = 1,500,204 couples; partnerships were formed between 1990-2023), we examined regional differences in partner similarity in mental disorders, educational attainment, and adolescent school performance. We also analysed geographical variation in partner similarity within three major cities. Accounting for local demographic composition of potential partners attenuated the partner similarity from r=0.43 to r=0.34 for highest obtained educational attainment, but increased partner similarity in any mental disorders from r=.40 to r=.42. In urban municipalities partners were more similar in educational attainment, but less in mental disorders, compared to more rural regions. We found no clear within-city variation in partner similarity. These findings highlight the role regional demographic composition plays in partnership formation and suggest different partnering dynamics depending on societal organization.
]]></description>
<dc:creator><![CDATA[ Soini, E., Golovina, K., Suokas, K., Gutvilig, M., Elovainio, M., Jokela, M., Hakulinen, C. ]]></dc:creator>
<dc:date>2026-06-25</dc:date>
<dc:identifier>doi:10.64898/2026.06.23.26356303</dc:identifier>
<dc:title><![CDATA[Regional variation and urban-rural differences in partner similarity: a nationwide cohort study]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory</dc:publisher>
<prism:publicationDate>2026-06-25</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://www.medrxiv.org/content/10.64898/2026.06.23.26356366v1?rss=1">
<title>
<![CDATA[
Sensitive periods for prenatal alcohol exposure shape internalizing symptoms across development 
]]>
</title>
<link>
https://www.medrxiv.org/content/10.64898/2026.06.23.26356366v1?rss=1
</link>
<description><![CDATA[
ImportancePrenatal alcohol exposure (PAE) is associated with lasting cognitive and neurodevelopmental deficits and can quadruple risk for depression later in life. However, it remains unknown whether there are specific trimesters when PAE is more strongly associated with longitudinal trajectories of internalizing symptoms - an indicator of depression risk - across childhood and adolescence.

ObjectiveTo investigate how PAE timing and dosage are associated with internalizing symptom trajectories from ages 4 to 16.5 years.

Design, Setting and ParticipantsWe analyzed prospective data from the Avon Longitudinal Study of Parents and Children (ALSPAC), an ongoing longitudinal birth cohort from the United Kingdom. Internalizing symptom trajectories were estimated for 6,409 participants. Primary analyses were conducted on 2,254 participants with complete data on PAE in all three trimesters, covariates, and trajectories.

Main Outcomes and MeasuresWe used growth mixture modelling to identify latent trajectories of depressive symptoms measured using the internalizing symptom scale from the Strengths and Difficulties Questionnaire (SDQ) at seven occasions between ages 4 to 16.5 years. Prospective alcohol consumption during each trimester were categorized into three PAE dosages: unexposed (0 drinks/week), low (1-7 drinks/week) and high (7+ drinks/week).

ResultsWe identified five distinct depressive symptom trajectories: stable low (75.9% of participants), moderate childhood peak (11.2%), progressive increase (5.57%), high early childhood (4.73%), and early adolescent peak (2.61%). PAE in the second (relative risk [RR]=2.08, 95% CI=1.15-3.76) and third trimesters (RR=1.83, 95% CI=1.05-3.21), as well as total PAE burden across pregnancy (RR=1.33, 95% CI=1.06-1.68) increased risk for the progressive increase trajectory, versus the stable low trajectory. High PAE in the second (RR=2.71, 95% CI=1.41-5.21) and third (RR=2.27, 95% CI=1.27-4.05) trimesters drove elevated risk for this trajectory. PAE in the first trimester or at low dosages showed no associations with depressive symptom trajectories. Negative control analyses of paternal drinking also found no associations.

Conclusions and RelevanceOur results highlight the second and third trimesters as potential sensitive periods for the impact of PAE on rising depressive symptoms from childhood to adolescence. Ultimately, these findings could inform the design of prevention programs, and facilitate targeted interventions to youth at elevated risk for depression.
]]></description>
<dc:creator><![CDATA[ Law, K. Y. T., Bigler, M. E., Kohrt, E., Kwong, A. S. F., Lussier, A. A. ]]></dc:creator>
<dc:date>2026-06-25</dc:date>
<dc:identifier>doi:10.64898/2026.06.23.26356366</dc:identifier>
<dc:title><![CDATA[Sensitive periods for prenatal alcohol exposure shape internalizing symptoms across development]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory</dc:publisher>
<prism:publicationDate>2026-06-25</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://www.medrxiv.org/content/10.64898/2026.06.23.26356304v1?rss=1">
<title>
<![CDATA[
Genetic overlap with schizophrenia and Parkinson's reveals psychomotor basis of physical activity 
]]>
</title>
<link>
https://www.medrxiv.org/content/10.64898/2026.06.23.26356304v1?rss=1
</link>
<description><![CDATA[
BackgroundPhysical activity levels are altered across neuropsychiatric disorders. While these traits are heritable, the genetic overlap between normal variation in activity levels and neuropsychiatric disorders that involve motor dysfunction such as schizophrenia and Parkinsons disease (PD) remains unexplored.

ObjectivesTo investigate the genetic overlap between physical activity, schizophrenia, and PD.

MethodsMulti-Trait Analysis of genome-wide association studies (GWAS) was used to boost the GWAS power for objectively measured physical activity (n=89,683) by leveraging three GWAS of self-reported activity (n=124,842-377,234). Genetic overlap between the activity, schizophrenia and PD was characterized using linkage disequilibrium score regression, causal mixture modeling, and local genetic correlations. Pleiotropic variants were identified using the conjunctional false discovery rate, annotated to genes, and investigated for enrichment of biological processes, tissue types and association with GWAS-catalog traits.

ResultsGenetic correlations of physical activity with schizophrenia and PD were negligible (rg=-0.02-0.02, p>0.05), but polygenic overlap was substantial, reflecting mixed effect directions. We identified 32 independent variants shared with schizophrenia and 11 with PD, including CRHR1, MAPT and KANSL1 within the 17q21.31 region. Schizophrenia-shared variants mapped to genes differentially expressed in subcortical regions, especially amygdala and basal ganglia. Gene-set analyses revealed enrichment for mental health and cognitive-behavioural traits (schizophrenia-shared genes) versus structural brain phenotypes and neurodegenerative disorders (PD-shared genes).

ConclusionsDespite negligible genetic correlations, physical activity shares substantial genetic architecture with schizophrenia and PD. Shared genes implicated brain regions and traits spanning motor and cognitive-affective function, consistent with the psychomotor nature of physical activity.
]]></description>
<dc:creator><![CDATA[ van der Walt, K., Shadrin, A., Tesfaye, M., van der Meer, D., Andreassen, O., Rokicki, J., Campbell, M. ]]></dc:creator>
<dc:date>2026-06-24</dc:date>
<dc:identifier>doi:10.64898/2026.06.23.26356304</dc:identifier>
<dc:title><![CDATA[Genetic overlap with schizophrenia and Parkinson's reveals psychomotor basis of physical activity]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory</dc:publisher>
<prism:publicationDate>2026-06-24</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://www.medrxiv.org/content/10.64898/2026.06.15.26355458v1?rss=1">
<title>
<![CDATA[
Risk factors for suicide and repeat self-harm: a cohort study of adults with hospital-presenting self-harm 
]]>
</title>
<link>
https://www.medrxiv.org/content/10.64898/2026.06.15.26355458v1?rss=1
</link>
<description><![CDATA[
BackgroundPrevious self-harm elevates the risk of repeat self-harm and suicide, but the prognostic value of events and clinician observations around the index event is unclear. We evaluated established and exploratory risk factors for suicide and repeat self-harm among patients presenting to emergency psychiatric units after a suicide attempt or nonsuicidal self-injury (NSSI).

MethodsMulticentre cohort study in Sweden (n = 804). Outcomes were suicide and repeat self-harm at 1-year and 5-year follow-up, ascertained through linked national registers. Established risk factors included psychiatric diagnoses, prior suicidal behaviour, and sociodemographic characteristics; exploratory factors comprised past-week self-reported symptom changes and clinician observations. LASSO-regularised Cox regression models were fitted for established (n=21) and exploratory (n=11) risk factors.

ResultsDuring five-year follow-up, 285 (35%) individuals had a new episode of self-harm and 41 (5%) died by suicide. No risk factors reached statistical significance for suicide, although male sex was retained after regularisation (1-year hazard ratio [HR] = 3.57 [95% CI 0-8.33]; 5-year HR = 2.5 [0.03-4.55]). Three established risk factors were significantly associated with repeat self-harm: psychiatric inpatient care in the three months before the index event (1-year HR = 1.85 [1.3-2.6]; 5-year HR = 1.72 [1.23-2.65]), previous suicide attempt (1-year HR = 2.01 [0.79-2.4]; 5-year HR = 2.19 [1.27-2.6]), and borderline personality disorder (1-year HR = 1.82 [1.13-3]; 5-year HR = 1.67 [0.14-2.75]). Among exploratory risk factors, clinician-observed hopelessness (1-year HR = 1.72 [1.1-2.3]; 5-year HR = 1.51 [1.03-1.91]) and personality disorder features (1-year HR = 1.48 [0.96-2.05]; 5-year HR = 1.47 [1.04-1.95]) were associated with repeat self-harm.

ConclusionsRisk factor profiles for repeat self-harm were consistent at 1 and 5 years. Beyond established risk factors, clinician-observed hopelessness and personality disorder features emerged as markers of risk, suggesting that qualitative clinician assessments may yield prognostic information not available from medical records alone.
]]></description>
<dc:creator><![CDATA[ Flygare, O., Bjureberg, J., Wallert, J., Doering, S., Salander Renberg, E., Waern, M., Runeson, B. ]]></dc:creator>
<dc:date>2026-06-24</dc:date>
<dc:identifier>doi:10.64898/2026.06.15.26355458</dc:identifier>
<dc:title><![CDATA[Risk factors for suicide and repeat self-harm: a cohort study of adults with hospital-presenting self-harm]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory</dc:publisher>
<prism:publicationDate>2026-06-24</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://www.medrxiv.org/content/10.64898/2026.06.22.26356249v1?rss=1">
<title>
<![CDATA[
Self-administered computerized cognitive training for cognitive deficits in individuals with metabolic syndrome: a randomized controlled trial 
]]>
</title>
<link>
https://www.medrxiv.org/content/10.64898/2026.06.22.26356249v1?rss=1
</link>
<description><![CDATA[
BackgroundMetabolic syndrome (MetS) has been associated with cognitive decline. Considering its increasing prevalence worldwide, the goal of this study was to evaluate the feasibility and efficacy of a short-term, self-administered computerized cognitive training programme in individuals with metabolic syndrome and low cognitive performances.

MethodsThirty six participants, aged 40-72 years (mean age: 57.8 years), were randomly assigned to the cognitive training or the passive control group. The cognitive training component of Long Lasting Memories (LLM) Care was used as an interactive software to enhance participants cognitive functions. Up to 24 sessions, each lasting 45 minutes, were self-administered at home twice per week for 3 months. Thorough cognitive assessments with were performed at baseline (randomization), at the end of intervention, and 12 months after baseline. The primary outcome was performance at nine neuropsychological tests, and the secondary outcome was a self-reported questionnaire assessing everyday functional abilities. Primary analyses were performed employing mixed-effect models using the intention-to-treat principle.

ResultsLow adherence was observed in the study, as only 9 participants (50%) completed at least 8 sessions of the cognitive training programme (range 9-24 sessions, median 15 sessions). No statistically significant effect of the cognitive training programme on performance in neuropsychological tests or everyday functioning was found. At the end of the 3-month intervention programme, effect for visual memory enhancement in immediate ({beta} = 1.58, 95% CI = -1.84 to 4.99, Cohens d = 0.39) and delayed recall ({beta} = 2.17, 95% CI = -1.68 to 6.01, Cohens d = 0.45) was moderate in favour of the intervention group, and at 12-month follow-up, semantic verbal fluency gains for the intervention group were detected ({beta} = 2.78, 95% CI = -0.92 to 6.49, Cohens d = 0.70), though with wide confidence intervals.

ConclusionsDespite some small effects observed in memory and verbal fluency, cognitive training did not yield statistically significant improvements. The observed low adherence and limited benefits on mild cognitive deficits in mostly middle-aged individuals with MetS are likely associated with the self-administered and short-term nature of the computerized intervention. This highlights the need for more intensive and clinician-delivered approaches to enhance engagement. Registry: ClinicalTrials.gov, TRN: NCT05658354, Registration date: 08 December 2022.
]]></description>
<dc:creator><![CDATA[ Koutsonida, M., Markozannes, G., Kanellopoulou, A., Tsiaras, Y., Varella, A., Zilidou, V., Romanopoulou, E., Hyphantis, T., Ntzani, E., Aretouli, E., Tsilidis, K. ]]></dc:creator>
<dc:date>2026-06-24</dc:date>
<dc:identifier>doi:10.64898/2026.06.22.26356249</dc:identifier>
<dc:title><![CDATA[Self-administered computerized cognitive training for cognitive deficits in individuals with metabolic syndrome: a randomized controlled trial]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory</dc:publisher>
<prism:publicationDate>2026-06-24</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://www.medrxiv.org/content/10.64898/2026.06.15.26355692v1?rss=1">
<title>
<![CDATA[
Biochemical fingerprinting of human scalp hair reveals endocannabinoid related compounds as potential biomarker indicators of altered mitochondrial bioenergetics in immune cells from female patients with major depressive disorder 
]]>
</title>
<link>
https://www.medrxiv.org/content/10.64898/2026.06.15.26355692v1?rss=1
</link>
<description><![CDATA[
Major depressive disorder (MDD) is a severe psychiatric disorder that affects more than 350 million people worldwide, yet its biomolecular mechanisms are incompletely understood, and clinically applicable markers remain elusive. To shed new light on the underlying pathophysiology of MDD across multiple research disciplines, we first used a biochemical fingerprinting approach with human hair (the first 3 cm cut from the scalp) to identify changes in the total set of detectable metabolites and lipids (metabolipidomics) using quadrupole time-of-flight mass spectrometry (qToF-MS). In this study, we focused on endocannabinoid (ECB)-related lipid compounds and identified 7 candidate markers that differed between depressed and non-depressed female participants. Two phosphatidylinositols, namely PI 24:0 and PI 37:4, showed dose-dependent associations with the severity of depressive symptoms. Finally, to bridge hair findings with previously reported results in blood, we tested associations between changes in identified ECB-related compounds and parameters of mitochondrial respiratory activity in peripheral blood mononuclear cells. We found 17 significant associations, with the strongest effects for the lipids PI 24:0, MGDG-O 16:3, PG 12:0, and PI 37:4. Our approach not only identified novel associations between endocannabinoid (ECB)-related lipid dysregulation and impaired mitochondrial energy metabolism in MDD but also revealed ECB-related lipids as a possible surrogate marker of impaired bioenergetic metabolism in MDD, at least in immune cells. More research is needed to replicate these findings, ideally by testing reversibility in longitudinal intervention studies and by including both sexes in larger cohorts.
]]></description>
<dc:creator><![CDATA[ Bondy, L., De Punder, K., Salinas-Manrique, J., Hennessy, T., Stoll, T., Hill, M. M., Dietrich, D. E., Karabatsiakis, A. ]]></dc:creator>
<dc:date>2026-06-24</dc:date>
<dc:identifier>doi:10.64898/2026.06.15.26355692</dc:identifier>
<dc:title><![CDATA[Biochemical fingerprinting of human scalp hair reveals endocannabinoid related compounds as potential biomarker indicators of altered mitochondrial bioenergetics in immune cells from female patients with major depressive disorder]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory</dc:publisher>
<prism:publicationDate>2026-06-24</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://www.medrxiv.org/content/10.64898/2026.06.22.26356085v1?rss=1">
<title>
<![CDATA[
Cognitive-emotional responses to ultrasonic neuromodulation of anterior cingulate cortex 
]]>
</title>
<link>
https://www.medrxiv.org/content/10.64898/2026.06.22.26356085v1?rss=1
</link>
<description><![CDATA[
The anterior cingulate cortex (ACC) is a key brain center involved in cognitive and emotional processing that is implicated in a variety of neuropsychiatric disorders including chronic pain and depression. Circuit-targeted diagnosis and treatment of these disorders will require the capacity to precisely modulate ACC subregions. Toward that end, we recently developed and validated a novel low-intensity transcranial focused ultrasound device that can noninvasively and directly modulate ACC subdivisions in humans with millimeter precision. Here we describe the subjective reports of 36 individuals diagnosed with either chronic pain or major depression who received repeated brief stimulation trials (807 active, 797 sham; duration 30s-3min) spanning the dorsoventral extent of the ACC. Sonication immediately altered cognitive-emotional states (odds ratio 5.6, active versus sham), eliciting a positive-valence experience more often than negative (29% versus 8%) in both diagnostic groups. Sham-adjusted response rate varied across ACC targets, with the largest effects (Cohens d [~] 0.8) observed in pregenual and subgenual ACC in subjects with chronic pain and depression, respectively. These rapid trial-by-trial responses to ACC stimulation predicted subsequent improvements in pain and depression severity at 24 hours. Collectively, these findings reveal that transcranial ultrasound can robustly evoke immediate, target-specific, clinically meaningful changes in cognitive-emotional state, demonstrating the potential of ultrasonic neuromodulation as a tool for individualized probing of circuit function and dysfunction.
]]></description>
<dc:creator><![CDATA[ Cooper, B. S., Koppelmans, V., Riis, T. S., Feldman, D. A., Kwon, S., Brashear, P., Guynn, M., Okifuji, A., Kubanek, J., Mickey, B. J. ]]></dc:creator>
<dc:date>2026-06-24</dc:date>
<dc:identifier>doi:10.64898/2026.06.22.26356085</dc:identifier>
<dc:title><![CDATA[Cognitive-emotional responses to ultrasonic neuromodulation of anterior cingulate cortex]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory</dc:publisher>
<prism:publicationDate>2026-06-24</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://www.medrxiv.org/content/10.64898/2026.06.21.26356195v1?rss=1">
<title>
<![CDATA[
Cognitive and Neuroimaging Biomarker Intra-Individual Variability in Alzheimer's Disease 
]]>
</title>
<link>
https://www.medrxiv.org/content/10.64898/2026.06.21.26356195v1?rss=1
</link>
<description><![CDATA[
BackgroundGreater cognitive intra-individual variability (IIV) reflects increased heterogeneous performance across cognitive domains and has been linked to a higher risk of Alzheimers disease (AD). However, it remains unclear whether cognitive IIV is linked to heterogeneous dispersion of regional AD pathology. Hence, we aimed to examine the association between cognitive IIV and AD neuroimaging biomarker IIV.

MethodsThis study included participants with normal cognition (CN) and mild cognitive impairment (MCI) from the Alzheimers Disease Neuroimaging Initiative. Cognitive IIV was computed as the within-person standard deviation of five domain-specific neuropsychological test z-scores. Four neuroimaging biomarker IIV metrics were similarly derived using regional amyloid-{beta} (n = 1,021), tau (n = 719), cortical thickness (n = 2,148), and combined amyloid-tau-neurodegeneration (ATN, n = 258). Associations between cognitive IIV and each biomarker IIV were evaluated using linear regression models, adjusted for relevant covariates.

ResultsHigher cognitive IIV was associated with greater biomarker IIV across amyloid-{beta} ({beta} = 0.039, SE = 0.014, p = .006), tau ({beta} = 0.196, SE = 0.033, p < .001), cortical thinning ({beta} = 0.036, SE = 0.008, p < .001), and ATN ({beta} = 0.176, SE = 0.043, p < .001). Interaction analyses revealed that the associations of cognitive IIV with tau IIV, cortical thickness IIV, and ATN IIV were stronger in MCI than CN individuals. Significant interactions between cognitive IIV and biomarker positivity status showed that the effect with amyloid-{beta} IIV was attenuated in A- ({beta} = 0.004, SE = 0.014, p = .78) but that the effect with tau IIV remained robust even in T-individuals ({beta} = 0.088, SE = 0.022, p < .001).

ConclusionElevated cognitive IIV is associated with greater heterogeneity in cortical dispersion of AD-related pathology, particularly in prodromal AD and in the presence of abnormal pathology. As a novel measure that captures variation in topographical scattering of AD pathological burden across the cortex, AD biomarker IIV may offer research and clinical utility beyond evaluating absolute biomarker load or thresholds.
]]></description>
<dc:creator><![CDATA[ Teo, M. H., Taong, M. R. Q., Kan, C. N., Tan, C. H. ]]></dc:creator>
<dc:date>2026-06-24</dc:date>
<dc:identifier>doi:10.64898/2026.06.21.26356195</dc:identifier>
<dc:title><![CDATA[Cognitive and Neuroimaging Biomarker Intra-Individual Variability in Alzheimer's Disease]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory</dc:publisher>
<prism:publicationDate>2026-06-24</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://www.medrxiv.org/content/10.64898/2026.06.22.26356231v1?rss=1">
<title>
<![CDATA[
Co-development of anxiety and depression in UK and Brazil youth; a cross-country comparison 
]]>
</title>
<link>
https://www.medrxiv.org/content/10.64898/2026.06.22.26356231v1?rss=1
</link>
<description><![CDATA[
ImportanceAnxiety and depression frequently co-occur and show developmentally patterned co-development from childhood to adolescence. Adult psychiatric outcomes vary according to the timing, sequencing, and persistence of early symptoms, yet it remains unclear whether patterns of co-development are comparable across high-income and low- and middle-income country contexts.

ObjectiveExamine joint developmental trajectories of anxiety and depression from childhood to adolescence and their associations with anxiety and depression diagnoses in young adulthood.

Design, Setting and ParticipantsPopulation-based prospective cohort studies in the UK (Avon Longitudinal Study of Parents and Children [ALSPAC], N=9,586) and Brazil (Pelotas 2004 Birth Cohort, N=3,815).

Main Outcomes and MeasuresTrajectories were derived using parallel-process latent growth models and latent class growth analyses of anxiety and depression using the Development and Well-Being Assessment at early childhood (6-7 years), middle childhood (10-11 years), and adolescence (13-15 years). Diagnoses of anxiety and depression at 18 years were assessed via the Clinical Interview Schedule (ALSPAC) and the Mini International Neuropsychiatric Interview (Pelotas).

ResultsPrevalence of anxiety and depression from early childhood to adolescence was similar across cohorts. Co-development was stronger in ALSPAC, with modest increases in both conditions, whereas in Pelotas, anxiety increased rapidly while depression showed little average change. In both cohorts, four trajectory classes were identified: stable-low (ALSPAC, 41%; Pelotas, 54%), increasing (31%; 28%), decreasing (23%; 15%), and persistent-high anxiety/increasing depression (5%; 3%). Compared with the stable-low class, youth in the increasing and persistent-high classes had elevated odds of depression (ALSPAC: OR=2.0 [95% CI, 1.4-2.8] and 4.2 [2.6-6.7]; Pelotas: 2.2 [1.5-3.3] and 2.9 [1.4-6.0]) and anxiety in young adulthood (ALSPAC: 1.6 [1.2-2.2] and 4.8 [3.2-7.0]; Pelotas: 1.7 [1.2-2.6] and 2.9 [1.5-5.8]). No increased risk was observed in the decreasing class.

Conclusions and RelevancePatterns of anxiety and depression co-development were comparable across the UK and Brazil, suggesting shared developmental pathways. However, more rapid increases in anxiety among Brazilian youth may reflect context-specific risk factors. Persistence or emergence beyond early childhood was critical for identifying later diagnostic risk in both settings, highlighting the importance of early monitoring and intervention.

Key pointsQuestion: How does the co-development of anxiety and depression from early childhood to adolescence differ between high-income (HICs) and low- and middle-income countries (LMICs)?

Findings: In this comparative longitudinal study of two population-based birth cohorts from the UK (N = 9,586) and Brazil (N = 3,815), trajectories of anxiety and depression co-development from childhood through adolescence were broadly similar across settings and were predictive of anxiety and depression diagnoses in young adulthood.

Meaning: Despite substantial socioeconomic and contextual differences between the UK and Brazil, developmental pathways of anxiety and depression co-development appear largely comparable, suggesting shared underlying developmental processes across these contexts.
]]></description>
<dc:creator><![CDATA[ Shakeshaft, A., Barrass, L., Farooq, B., Riglin, L., Goncalves Soares, A. L., Jones, H. J., Lidbetter, N., Knipe, D. J., Penton-Voak, I., Carpena, M. X., dos Santos, I. S., Tovo-Rodrigues, L., Heron, J., Rice, F., Matijasevich, A., Howe, L. D. ]]></dc:creator>
<dc:date>2026-06-24</dc:date>
<dc:identifier>doi:10.64898/2026.06.22.26356231</dc:identifier>
<dc:title><![CDATA[Co-development of anxiety and depression in UK and Brazil youth; a cross-country comparison]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory</dc:publisher>
<prism:publicationDate>2026-06-24</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://www.medrxiv.org/content/10.64898/2026.06.21.26356048v1?rss=1">
<title>
<![CDATA[
Changes in hierarchical brain dynamics of rumination following mindfulness-based cognitive therapy for depression 
]]>
</title>
<link>
https://www.medrxiv.org/content/10.64898/2026.06.21.26356048v1?rss=1
</link>
<description><![CDATA[
Major depressive disorder (MDD) is a leading cause of disability worldwide with risk of onset and recurrence linked to depressive ruminative thought patterns. Mindfulness-based cognitive therapy (MBCT) is an evidence-based treatment for depression that targets the ability to recognise, decenter, and disengage from ruminative thought patterns. Elucidating how MBCT impacts hierarchical brain organisation may be key to understanding the processes by which MBCT can modulate ruminative tendencies. In a randomised controlled functional magnetic resonance imaging (fMRI) trial on individuals with MDD (N=80) before and after MBCT in addition to treatment as usual (TAU), we investigated changes in hierarchical brain organisation during resting-state and rumination. We built whole-brain models to obtain generative connectivity (GEC) matrices per patient and quantified brain hierarchy by measuring the global directedness and regional trophic levels in each GEC, in which greater directedness reflects more directional information flow and less recurrence. Global directedness in MBCT+TAU compared to TAU increased during rumination, with no changes during resting-state. Furthermore, increased regional breadth of hierarchy during rumination was related to improvements in clinical and behavioural outcomes following MBCT+TAU. Increased brain hierarchy during rumination following mindfulness training may be consistent with a shift away from self-reinforcing negative mental loops towards more differentiated and less coupled cognitive and bodily cycles, supporting MBCTs ability to interrupt ruminative processes. Hierarchical brain dynamics may hold promise as a treatment-sensitive marker and a potential mechanism of therapeutic change in MBCT for depression.

Trial registrationClinicalTrials.gov NCT03353493.
]]></description>
<dc:creator><![CDATA[ Dagnino, P. C., van der Velden, A. M., Ruhe, H. G., Kuyken, W., Kringelbach, M. L., Vohryzek, J., Deco, G. ]]></dc:creator>
<dc:date>2026-06-23</dc:date>
<dc:identifier>doi:10.64898/2026.06.21.26356048</dc:identifier>
<dc:title><![CDATA[Changes in hierarchical brain dynamics of rumination following mindfulness-based cognitive therapy for depression]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory</dc:publisher>
<prism:publicationDate>2026-06-23</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://www.medrxiv.org/content/10.64898/2026.06.21.26356164v1?rss=1">
<title>
<![CDATA[
Post Hoc Localization of Beam F3 Stimulation Targets: An MRI-Derived Geodesic Approach for Refined TMS E-Field Simulations 
]]>
</title>
<link>
https://www.medrxiv.org/content/10.64898/2026.06.21.26356164v1?rss=1
</link>
<description><![CDATA[
BackgroundTranscranial magnetic stimulation (TMS) targeting the left dorsolateral prefrontal cortex (dlPFC) is an established treatment option in major depressive disorder. One of the most common approaches for targeting the dlPFC is the Beam F3 method, which determines the stimulation site (F3Beam) as a function of external cranial measurements. Precise knowledge of the individual stimulation site is essential for imaging-based analyses of TMS effects. However, due to the methods reliance on individual anatomy, retrospective identification of F3Beam targets across cohorts is challenging, limiting the analysis of existing datasets. We developed a scalable method to reconstruct subject-specific F3Beam target locations for e-field simulations based on structural imaging.

MethodsHigh-resolution three-dimensional (3D) T1-weighted MRI was used to generate individual scalp meshes via the "Simulation of Non-Invasive Brain Stimulation" (SimNIBS) software. Subject-specific anatomical distances and coordinates of interest were measured geodesically using a Python-based script to reconstruct the individual F3Beam targets. Validation included a retrospective comparison between digital geodesic measurements and manual cranial measurements in 20 patients and a prospective comparison with MR-visible scalp markers in 2 healthy controls. To assess the impact of our targeting algorithm on e-field simulations, volumetric e-field maps based on three potential targets (F3Beam, F3MNI, F3Geo) were generated in SimNIBS and compared using voxel-wise statistics in SPM12.

ResultsRetrospective analysis revealed a systematic bias towards higher in vivo measurements compared to digital geodesic measurements, though deviations in the final distances determining F3Beam (xBeam and yBeam) were minimal ({Lambda}xBeam: 0.11 {+/-} 0.08 cm; {Lambda}yBeam: 0.14 {+/-} 0.21 cm). Prospective validation demonstrated that F3Beam coordinates better matched in vivo coil positions than group-template-derived targets (F3MNI). Group-level analysis showed method-dependent clustering of coil positions with corresponding voxel-wise e-field differences.

ConclusionsIndividualized geodesic measurements may enable accurate, scalable and retrospective identification of Beam F3 targets and coil orientations. This approach may yield more accurate e-field simulations than group-template based targeting and provides a practical method for retrospective analysis of existing TMS treatment cohorts. This could be leveraged to identify response predictors or imaging-based biomarkers of treatment response.
]]></description>
<dc:creator><![CDATA[ Schramm, S., Ten Pas, J., Calabro, D., Jakubetz, J., Szillat, M., Koti, J., Huang, M., Kim, S. H., Woletz, M., Kirschke, J., Hedderich, D. M., Sollmann, N., Tik, M., Vogelmann, U. ]]></dc:creator>
<dc:date>2026-06-23</dc:date>
<dc:identifier>doi:10.64898/2026.06.21.26356164</dc:identifier>
<dc:title><![CDATA[Post Hoc Localization of Beam F3 Stimulation Targets: An MRI-Derived Geodesic Approach for Refined TMS E-Field Simulations]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory</dc:publisher>
<prism:publicationDate>2026-06-23</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://www.medrxiv.org/content/10.64898/2026.06.20.26356092v1?rss=1">
<title>
<![CDATA[
Associations Between Social Responsiveness and Sleep Disruption are Modulated by Chronotype in Early Adolescence: Cross-Sectional and Prospective Findings from 10,108 Participants of the Adolescent Brain and Cognitive Development (ABCD) Study 
]]>
</title>
<link>
https://www.medrxiv.org/content/10.64898/2026.06.20.26356092v1?rss=1
</link>
<description><![CDATA[
Study ObjectivesSleep disturbance is prevalent in people with neurodevelopmental disorders such as autism, but is not clear whether it occurs as an endophenotype or secondary to other behaviours. The ABCD Study is a population-based longitudinal study that monitors the health, demography and lifestyle of over 11,000 children in the US. In this study we leverage these data to investigate whether traits consistent with autism (social responsiveness) are associated with sleep disturbance independent of lifestyle and other behavioural measures.

MethodsAutistic traits were assessed using the Social Responsiveness Scale at age 11, and sleep disturbance and behavioural outcomes were assessed at ages 11 and 13 years using the Sleep Disturbance Scale, and the Child Behaviour Check List, respectively. Demographic, health and lifestyle-related variables were assessed by caregiver questionnaires. Regression models were applied to investigate associations between autistic traits and sleep outcomes.

ResultsThere was a significant cross-sectional association between sleep disturbance and SRS at age 11 years old that was independent of sex, ethnicity, socioeconomic position, physical activity, sedentary behaviour and anxiety/depression ({beta} = 0.12, 95% CI (0.07, 0.17); p < 0.001), that persisted at age 13, and that was modulated by chronotype, with evening types showing a stronger association.

ConclusionsSocial responsiveness assessed in early adolescence (age 11) were associated with sleep disturbance independent of multiple confounding factors and were prospectively associated with sleep disturbance at age 13 years. These findings contribute to the evidence that disruption of sleep and circadian timing may have a primary role in the mechanisms that mediate autistic traits.

Statement of significanceSleep disturbance is prevalent in people with neurodevelopmental conditions including autism and is associated with the severity of social, behavioural, and sensory symptoms. Evidence from studies of high-risk infants and animal models suggest that sleep problems emerge early in development, and may reflect underlying neurobiological vulnerability rather than secondary effects of other aspects of neurodevelopmental conditions. This study provides population-level evidence that autistic traits are independently and longitudinally associated with sleep disturbance across early adolescence. This relationship was moderated by chronotype, was stronger in females, and clustered within families, implicating shared circadian or genetic mechanisms. Future research should focus on prospective and mechanistic studies to assess the aetiological significance of sleep disturbance in autism.
]]></description>
<dc:creator><![CDATA[ Wyse, C., Vasconcelos, M., Nordon, E., phyo, a., Lopez, L. M. ]]></dc:creator>
<dc:date>2026-06-23</dc:date>
<dc:identifier>doi:10.64898/2026.06.20.26356092</dc:identifier>
<dc:title><![CDATA[Associations Between Social Responsiveness and Sleep Disruption are Modulated by Chronotype in Early Adolescence: Cross-Sectional and Prospective Findings from 10,108 Participants of the Adolescent Brain and Cognitive Development (ABCD) Study]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory</dc:publisher>
<prism:publicationDate>2026-06-23</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://www.medrxiv.org/content/10.64898/2026.06.12.26355506v1?rss=1">
<title>
<![CDATA[
The Protective Role of Belonging and Socioeconomic Status in Dropout Intent Among Minority Ethnic Students: A Mixed Methods Study 
]]>
</title>
<link>
https://www.medrxiv.org/content/10.64898/2026.06.12.26355506v1?rss=1
</link>
<description><![CDATA[
Improving minority ethnic student retention is a global higher education priority. This mixed-methods study investigated how institutional belonging and socioeconomic status interact to shape dropout intentions among minority university students in the UK (N = 182). Quantitative results revealed that perceived course difficulty and lower subjective socioeconomic status were the strongest predictors of dropout intent. While the interaction between socioeconomic status and difficulty was non-significant, qualitative accounts showed distinct structural vulnerabilities. Financial strain restricted social integration, turning socioeconomic disparities into campus isolation. Conversely, representative curricula, diverse peer networks, and stable cultural in-groups (e.g., religious affiliations, living in the parental home) functioned as essential psychological buffers against academic exhaustion and alienation. Universities must shift from transactional models to sustained structural equity to protect vulnerable student groups.
]]></description>
<dc:creator><![CDATA[ Vaportzis, E., Khan, M., George, K. K. ]]></dc:creator>
<dc:date>2026-06-22</dc:date>
<dc:identifier>doi:10.64898/2026.06.12.26355506</dc:identifier>
<dc:title><![CDATA[The Protective Role of Belonging and Socioeconomic Status in Dropout Intent Among Minority Ethnic Students: A Mixed Methods Study]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory</dc:publisher>
<prism:publicationDate>2026-06-22</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://www.medrxiv.org/content/10.64898/2026.06.18.26355841v1?rss=1">
<title>
<![CDATA[
Evidence-guided AI regularization for suicidal ideation prediction in pediatric bipolar disorder 
]]>
</title>
<link>
https://www.medrxiv.org/content/10.64898/2026.06.18.26355841v1?rss=1
</link>
<description><![CDATA[
BackgroundSuicide prediction models in psychiatry often rely on purely data-driven feature selection, which can produce unstable and clinically opaque predictor sets in modest-sized samples. We developed Evidence-Based AI LASSO (EBAL), an evidence-guided regularization framework that incorporates curated clinical evidence into feature-specific penalty factors for interpretable prediction.

MethodsBaseline data from 136 youth with confirmed bipolar spectrum disorder in the Greater Houston Area Bipolar Registry were analyzed using 20 candidate clinical predictors. Forty higher-level evidence documents on suicidality and related predictor domains were curated through a structured evidence synthesis workflow and indexed as an auditable evidence corpus. An open-weight large language model assigned feature-specific penalty factors using a prespecified scoring rubric, and these penalties were used to fit a weighted LASSO model. EBAL was compared with a standard evidence-agnostic LASSO using nested leave-one-out cross-validation.

ResultsFor suicidal ideation, EBAL achieved an AUROC of 0.768, balanced accuracy of 0.757, sensitivity of 0.758, and specificity of 0.757. The standard LASSO achieved an AUROC of 0.760 and balanced accuracy of 0.715. EBAL improved balanced accuracy (+0.042, p=0.010) and Matthews correlation coefficient (+0.079, p=0.010), while retaining fewer stable predictors than standard LASSO (11/20 vs 18/20). The strongest positive predictors were current depressed mood, duration of mood disorder illness, and comorbid generalized anxiety disorder. For suicidal behavior, both models performed near chance and retained all candidate predictors.

LimitationsThe study was cross-sectional, single-site, and modest in sample size, with no external validation cohort.

ConclusionsEBAL produced a sparser and more clinically coherent model for suicidal ideation in pediatric bipolar disorder, but did not improve prediction of suicidal behavior. These findings support evidence-guided regularization as a transparent strategy for aligning psychiatric prediction models with prior clinical knowledge while preserving interpretability.
]]></description>
<dc:creator><![CDATA[ Jabbar Abdl Sattar Hamoudi, H., Wu, M.-J., Sanches, M., Zunta-Soares, G. B., Soutullo, C. A., Soares, J. C., Mwangi, B. ]]></dc:creator>
<dc:date>2026-06-22</dc:date>
<dc:identifier>doi:10.64898/2026.06.18.26355841</dc:identifier>
<dc:title><![CDATA[Evidence-guided AI regularization for suicidal ideation prediction in pediatric bipolar disorder]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory</dc:publisher>
<prism:publicationDate>2026-06-22</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://www.medrxiv.org/content/10.64898/2026.06.18.26355974v1?rss=1">
<title>
<![CDATA[
The Effects of Serotonergic systems on Cognitive Flexibility and Perseverative Thinking: a comparison between SSRI, classical psychedelics, and acute tryptophan depletion in a Multilevel Meta-Analysis 
]]>
</title>
<link>
https://www.medrxiv.org/content/10.64898/2026.06.18.26355974v1?rss=1
</link>
<description><![CDATA[
BackgroundSerotonin has been implicated in cognitive flexibility and pathological perseverative thinking (PT), including rumination, worry, and obsessions. However, evidence remains fragmented across pharmacological manipulations, clinical populations, and outcome measures. This multilevel meta-analysis examined whether serotonergic interventions influence PT and cognitive flexibility.

MethodsPreregistered and following PRISMA guidelines, we synthesized studies investigating three classes of serotonergic manipulations: acute tryptophan depletion (ATD), serotonin elevation via selective serotonin reuptake inhibitors (SSRIs), and classic serotonergic psychedelics. Three multilevel random-effects meta-analyses with cluster-robust variance estimation were conducted: (A) effects of ATD on cognitive flexibility (N = 266; 10 effect sizes), (B) effects of serotonin elevation on cognitive flexibility (N = 654; 15 effect sizes), and (C) effects of serotonin elevation on pathological perseverative thinking (N = 1,100; 20 effect sizes). Across analyses, the total sample comprised 2,030 participants and 45 effect sizes.

ResultsATD did not significantly impair cognitive flexibility (g = 0.15, 95% CI [-0.07, 0.38], p =.23), and no moderation by task type, sex, or age was observed. Serotonin elevation similarly did not improve cognitive flexibility (g =-0.07, 95% CI [-0.36, 0.22], p =.63), with no significant performance differences emerging between SSRIs, classical psychedelics, or tryptophan enrichment. In contrast, serotonin elevation was associated with a significant medium-to-large reduction in perseverative thinking (g =-0.58, 95% CI [-0.76,-0.41], p <.001). Notably, while both pharmacological classes effectively reduced cognitive rigidity, SSRIs demonstrated a marginally smaller magnitude of symptom reduction compared to acute psilocybin interventions (p =.081). Furthermore, samples with a higher proportion of female participants showed larger reductions in perseverative thinking ({beta} =-1.86, p =.014), while worries exhibited marginally smaller reductions relative to obsessions ({beta} = 0.42, p =.055). Publication bias tests were non-significant across analyses.

ConclusionsSerotonergic interventions robustly reduce perseverative thinking but do not consistently alter performance on laboratory measures of cognitive flexibility. These findings suggest that serotonin may influence cognitive-emotional rigidity and the subjective experience of repetitive thought more strongly than objective executive task performance. The dissociation between task-based and phenomenological outcomes aligns with contemporary models of serotonergic plasticity and highlights perseverative thinking as a potentially transdiagnostic therapeutic target of serotonergic interventions.
]]></description>
<dc:creator><![CDATA[ Basch, R., Cohen, M., Peled-Avron, L. ]]></dc:creator>
<dc:date>2026-06-22</dc:date>
<dc:identifier>doi:10.64898/2026.06.18.26355974</dc:identifier>
<dc:title><![CDATA[The Effects of Serotonergic systems on Cognitive Flexibility and Perseverative Thinking: a comparison between SSRI, classical psychedelics, and acute tryptophan depletion in a Multilevel Meta-Analysis]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory</dc:publisher>
<prism:publicationDate>2026-06-22</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://www.medrxiv.org/content/10.64898/2026.06.18.26355956v1?rss=1">
<title>
<![CDATA[
Blood-Based Biomarkers Predict Differential Longitudinal Decline in Alzheimer's Disease Psychosis: Evidence from Two Cohorts 
]]>
</title>
<link>
https://www.medrxiv.org/content/10.64898/2026.06.18.26355956v1?rss=1
</link>
<description><![CDATA[
INTRODUCTIONPsychosis affects 40% of individuals with Alzheimers disease (AD) and is associated with accelerated cognitive decline. Blood-based biomarkers, particularly plasma phosphorylated tau (ptau), have demonstrated utility in predicting cognitive decline in AD, with ptau217 showing superior performance in many studies. However, whether these biomarkers predict differential cognitive trajectories in AD with psychosis (ADP) remains unknown.

METHODSTwo independent cohorts were analyzed: Alzheimers Disease Neuroimaging Initiative (ADNI; n=659: 172 cognitively unimpaired [CU], 406 AD, 81 ADP) and Litwin-Zucker Research Center (LZ; n=142: 68 CU, 57 AD, 17 ADP) with 6-year follow-up. Psychosis was defined by non-zero Neuropsychiatric Inventory delusions or hallucinations scores. In ADNI, plasma ptau181, ptau217, ptau231, amyloid-{beta}42/40, GFAP, and NfL were quantified using NULISA. In LZ, ptau181, ptau205, ptau212, ptau217, amyloid-{beta}42/40, GFAP, and NfL were quantified using Simoa. Linear mixed-effects models assessed prediction of cognitive decline across memory, language, visuospatial, and executive function domains.

RESULTSIn ADNI, baseline ptau181 predicted differential ADP decline in language (p<0.05), visuospatial (p<0.05), and executive function (p<0.05); ptau217 predicted language (p<0.05) and visuospatial (p<0.05) decline; GFAP predicted language (p<0.05) and visuospatial (p<0.05) decline; and NfL visuospatial decline (p=0.01). In LZ, ptau181 predicted decline in memory (p<0.05), language (p<0.0001), visuospatial (p<0.05), and executive function (p<0.05); ptau217 predicted memory (p<0.05) and visuospatial (p<0.05) decline; and GFAP predicted language decline (p<0.05). Johnson-Neyman analyses revealed ADP-AD divergence at low ptau181 thresholds in ADNI, while LZ showed crossover patterns with steeper ADP decline at low biomarker levels that attenuated at high levels where AD decline was steeper.

DISCUSSIONADP exhibited accelerated cognitive decline across domains driven by a distinct biomarker landscape compared to non-psychotic AD. Plasma ptau181 demonstrated broader domain-specific associations with decline in ADP than other blood-based biomarkers and associated exclusively with executive function impairment, indicating its unique utility for predicting cognitive trajectories in this pathophysiological subtype.
]]></description>
<dc:creator><![CDATA[ Gomar, J. J., Gordon, M. L., Christen, E., Giliberto, L., Keehlisen, L., Gong, M., Hoehn, N., Morley, E., O'Neil, A., Wuelfing, D., Malyavantham, K., Greenwald, B., Marambaud, P., Adrien, L., Jimenez, H., Davies, P., Koppel, J. ]]></dc:creator>
<dc:date>2026-06-22</dc:date>
<dc:identifier>doi:10.64898/2026.06.18.26355956</dc:identifier>
<dc:title><![CDATA[Blood-Based Biomarkers Predict Differential Longitudinal Decline in Alzheimer's Disease Psychosis: Evidence from Two Cohorts]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory</dc:publisher>
<prism:publicationDate>2026-06-22</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://www.medrxiv.org/content/10.64898/2026.06.19.26356081v1?rss=1">
<title>
<![CDATA[
Shared genetic and environmental influences between the broad avoidant/restrictive food intake disorder phenotype and neurodevelopmental traits: a twin study 
]]>
</title>
<link>
https://www.medrxiv.org/content/10.64898/2026.06.19.26356081v1?rss=1
</link>
<description><![CDATA[
ImportanceAvoidant/restrictive food intake disorder (ARFID) is a feeding and eating disorder characterized by extremely restricted dietary variety and/or quantity resulting in significant physical health impairment and psychosocial dysfunction. ARFID frequently co-occurs with neurodevelopmental conditions, yet the extent to which this co-occurrence reflects shared genetic or environmental influences remains largely unknown, as few twin or genetic studies of ARFID have been conducted.

ObjectiveTo examine the extent to which genetic and environmental influences contribute to the association between a broad ARFID phenotype and neurodevelopmental traits.

Design, Setting, and ParticipantsPopulation-based twin study using data from the Child and Adolescent Twin Study in Sweden, including 30,374 twins born 1992-2008.

Main Outcomes and MeasuresA broad ARFID phenotype was identified using a composite measure derived from parent reports and national health registers between ages 6 and 12 years. Parents completed measures of neurodevelopmental traits at age 9 or 12 years, including autism (subdomains: social communication problems and restricted/repetitive behaviors), attention-deficit/hyperactivity disorder (ADHD, subdomains: inattention and impulsivity/hyperactivity), tic disorders, learning disorders, oppositional defiant disorder, conduct disorder, obsessive-compulsive disorder (OCD), sensory perception problems, and sleep problems. Phenotypic associations were estimated using polyserial correlations. Bivariate twin models decomposed variance and covariance into genetic and environmental components.

ResultsPhenotypic correlations with the broad ARFID phenotype ranged from 0.18 (95% CI: 0.15-0.21) for OCD to 0.36 (95% CI: 0.33-0.38) for autism. Broad genetic correlations (rH; additive plus dominant genetic influences) ranged from 0.27 (95% CI: 0.21-0.33) for conduct disorder to 0.52 (95% CI: 0.44-0.60) for autism-restricted/repetitive behaviors. Genetic factors explained 77% to 95% of all phenotypic correlations. Non-shared environmental correlations were minimal to small, with the largest observed for autism (0.17; 95% CI: 0.08-0.26).

Conclusions and RelevanceThe broad ARFID phenotype shares substantial genetic influences with a number of neurodevelopmental traits. These findings suggest that the frequent co-occurrence of ARFID with neurodevelopmental traits largely reflects shared genetic influences rather than overlapping environmental influences, supporting the conceptualization of ARFID within a broader neurodevelopmental framework.
]]></description>
<dc:creator><![CDATA[ Qi, B., Hog, L., Lichtenstein, P., Lundstrom, S., Larsson, H., Bulik, C. M., Kuja-Halkola, R., Taylor, M. J., Dinkler, L. ]]></dc:creator>
<dc:date>2026-06-22</dc:date>
<dc:identifier>doi:10.64898/2026.06.19.26356081</dc:identifier>
<dc:title><![CDATA[Shared genetic and environmental influences between the broad avoidant/restrictive food intake disorder phenotype and neurodevelopmental traits: a twin study]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory</dc:publisher>
<prism:publicationDate>2026-06-22</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://www.medrxiv.org/content/10.64898/2026.06.18.26355880v1?rss=1">
<title>
<![CDATA[
Trial protocol: A hybrid effectiveness-implementation study of Paediatric Autism Communication Therapy (PACT) in the Brazilian public health system 
]]>
</title>
<link>
https://www.medrxiv.org/content/10.64898/2026.06.18.26355880v1?rss=1
</link>
<description><![CDATA[
In Brazil, autistic children and their families face significant challenges in accessing evidence-based interventions, especially via the national public health service. Here, we report the protocol for a hybrid effectiveness-implementation trial, which will investigate the large-scale implementation of Paediatric Autism Communication Therapy (PACT) as well as its real-world effectiveness in Brazilian public health services for autistic children. Eligible professionals from public health services across the five regions of Brazil will be trained in PACT. They will deliver the intervention, which consists of 14 sessions delivered over 6 months, to dyads of autistic children and their caregivers in their regular clinical practice for the trial period of 18 months. We will use elements of three implementation science frameworks to systematically study factors that influence the implementation of PACT in this setting. To study effectiveness dyads will be randomised to receive PACT immediately or following a 6-month waitlist, stratified by healthcare service. Effectiveness outcomes (parent-child interaction, child adaptive social communication skills, caregiver well-being) will be collected pre- and post-PACT/waitlist and compared between groups. This trial will provide the first evidence on the effectiveness of PACT implemented in a public health system and the barriers and facilitators to such large-scale implementation.

Lay abstractIn Brazil, many autistic children and their families struggle to access early, evidence-based support through the public health system. This study aims to help change that. We will test how a well-established intervention, called Paediatric Autism Communication Therapy (PACT), can be delivered at a large scale in Brazilian public health services, and whether it works effectively in real-world conditions. PACT works by helping caregivers understand their autistic childs communication and to respond in supportive ways that promote their childs social communication development. For this project, professionals from public health services across all five geographical regions of Brazil will receive training to deliver PACT to autistic children and their caregivers as part of their routine clinical work. Each family will be offered 14 sessions over six months, and the study will run for a total of 18 months. To understand how PACT can be used successfully across the Brazilian public health services, we will examine what helps or hinders implementation using established frameworks from implementation science. We will also evaluate how well the intervention works by comparing families who start PACT immediately with those who begin after a short wait. We will assess changes in caregiver-child interactions, childrens social communication and well-being, and caregiver well-being. This will be the first study to examine an evidence-based therapy for autistic children and their caregivers implemented at scale in the Brazilian public health system. The findings will guide policymakers, health services, and communities on how to improve access to high-quality early support for autistic children and their families in Brazil.
]]></description>
<dc:creator><![CDATA[ Godoy, P. B. G., Windlin, I. C., Cardoso, L. M. d. S., Yoshida, J., Lopes, D. C. P., Arruda, K. d. S., Junior, P. C. P. d. O., de Aquino, I. F., Alves, R. P., Constancio, T. N., Aguiar, I. M., dos Santos, T. F., Diniz, D. L. N., Lilge, L. A. L. C., de Castro, M. P., Proenca, J. d. B. S. C., Prazeres, G. d. A., Molina-Avejonas, D., Salomone, E., Leadbitter, K., Green, J., Shephard, E. ]]></dc:creator>
<dc:date>2026-06-22</dc:date>
<dc:identifier>doi:10.64898/2026.06.18.26355880</dc:identifier>
<dc:title><![CDATA[Trial protocol: A hybrid effectiveness-implementation study of Paediatric Autism Communication Therapy (PACT) in the Brazilian public health system]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory</dc:publisher>
<prism:publicationDate>2026-06-22</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://www.medrxiv.org/content/10.64898/2026.06.17.26354096v1?rss=1">
<title>
<![CDATA[
Mapping abstraction and metacognition onto distinct transdiagnostic symptom profiles 
]]>
</title>
<link>
https://www.medrxiv.org/content/10.64898/2026.06.17.26354096v1?rss=1
</link>
<description><![CDATA[
Transdiagnostic psychiatric research on reward-guided learning has largely focused on simple associative processes, leaving it unclear whether or how higher-level processes are disrupted. Here, we studied how abstraction, the ability to extract relevant features from complex information, and metacognition, the ability to monitor and evaluate ones own mental processes, map onto specific transdiagnostic dimensions. Using an online sample (N = 249), we examined associations between these processes and three cross-culturally robust transdiagnostic dimensions derived from a large existing dataset (N = 19,505): Compulsive hypersensitivity, Social withdrawal, and Addictive behaviours. Computational modelling of an abstract representation learning task with confidence judgments revealed that Compulsive hypersensitivity was negatively associated with both abstraction ability (pboot = 0.003) and metacognitive sensitivity (pboot = 0.005), while Social withdrawal was positively associated with metacognitive sensitivity alone (pboot = 0.002). Moreover, transdiagnostic dimensions revealed more coherent associations with higher-order cognition than symptom-level analyses, highlighting the added value of examining psychopathology at the factor rather than the symptom level. These findings portray a hierarchical view of cognitive dysfunctions in psychopathology and point to representational and metacognitive processes as potential targets for transdiagnostic intervention.
]]></description>
<dc:creator><![CDATA[ Oka, T., Kunisato, Y., Koizumi, K., Murakami, M., Six, H., Taylor, J. E., Cortese, A. ]]></dc:creator>
<dc:date>2026-06-22</dc:date>
<dc:identifier>doi:10.64898/2026.06.17.26354096</dc:identifier>
<dc:title><![CDATA[Mapping abstraction and metacognition onto distinct transdiagnostic symptom profiles]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory</dc:publisher>
<prism:publicationDate>2026-06-22</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://www.medrxiv.org/content/10.64898/2026.06.11.26355007v1?rss=1">
<title>
<![CDATA[
Effectiveness of Stress Management to Reduce Stress Eating for Women: A Systematic Review and Meta-analysis of Intervention Studies 
]]>
</title>
<link>
https://www.medrxiv.org/content/10.64898/2026.06.11.26355007v1?rss=1
</link>
<description><![CDATA[
ObjectiveThis systematic review and meta-analysis examined 1) the effects of stress management interventions on changes in stress eating for women, and 2) the longevity of these effects, by summarizing and assessing evidence from controlled and non-equivalent pretest-posttest intervention studies.

MethodFive databases (PsycINFO, PubMed, Medline, Web of Science, CINAHL), existing sources, and grey literature were searched (February - June 2025). Studies that assessed stress eating or emotional eating, included a stress management intervention, and comprised at least 70% women were included. The primary outcome was reduction in stress eating. Data were pooled in meta-analyses using multi-level random-effects models and subset by follow-up period. Risk of bias was assessed via funnel plots and sensitivity analyses.

ResultsSixty studies with 119 effect size estimates were included in the primary analysis. Pooled estimates indicated that stress management interventions significantly reduced stress eating (Hedges g = -0.4174, p < 0.001), with pre-post designs having larger effects than controlled trials. Subgroup analyses of follow-up periods found small effects in the short-term (before 3 months; Hedges g = -0.4202, p < 0.0001) and moderate effects for mid-term (3-6 months; Hedges g = -0.5886, p < 0.0001). Effects beyond 6 months were small and nonsignificant (Hedges g = -0.4370, p = 0.0660).

Conclusion and RelevanceStress management interventions appear to be effective for reducing stress eating for women, suggesting the potential to incorporate stress management in interventions targeting obesity. Effects may be only sustained 6 months post-intervention, suggesting the need for strategies to bolster long-term effectiveness.
]]></description>
<dc:creator><![CDATA[ Volpe, V. V., Collins, A. N., Davis, E. M., Badejoh, O. O., Allen, M., Holland, M. C., Ross, J. M., Braden, A., Kirk, K. F., Hector, E. C. ]]></dc:creator>
<dc:date>2026-06-22</dc:date>
<dc:identifier>doi:10.64898/2026.06.11.26355007</dc:identifier>
<dc:title><![CDATA[Effectiveness of Stress Management to Reduce Stress Eating for Women: A Systematic Review and Meta-analysis of Intervention Studies]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory</dc:publisher>
<prism:publicationDate>2026-06-22</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://www.medrxiv.org/content/10.64898/2026.06.17.26355864v1?rss=1">
<title>
<![CDATA[
Stroboscopic Light Stimulation in Adults Reporting Depressive Symptoms: Safety, Tolerability, Feasibility, and Active-Comparator Development in a Staged Early-Phase Study 
]]>
</title>
<link>
https://www.medrxiv.org/content/10.64898/2026.06.17.26355864v1?rss=1
</link>
<description><![CDATA[
Stroboscopic light stimulation (SLS) is a candidate non-pharmacological intervention that induces transient visual and affective experiences, with potential application in depression. Before efficacy testing, clinical development requires safety, tolerability and feasibility data. We report a staged, single-site programme in adults reporting depressive symptoms. Work Package (WP) 1 tested 11 SLS parameter sets for safety and tolerability. An interim bridge study assessed whether a low-phenomenology SLS control reduced subjective visual effects while preserving session context. WP2 randomised 84 participants to four weekly supervised 31-minute sessions of the intervention or a low-phenomenology control. In WP1, 31 participants were analysed; no severe adverse reactions occurred, mean discomfort was low (0.49/10), and the highest session-level upper 80% confidence limit was 1.13/10, well below the prespecified threshold. The interim study supported experiential separation between intervention and control. In WP2, endpoint data were available for 70/84 participants (83.3%): 39/42 in the intervention arm and 31/42 in the control arm. Overall retention met the criterion, but lower control-arm retention remains a design issue; protocol adherence was high, discomfort remained low, and no serious SLS-attributable adverse events occurred. Exploratory depressive-symptom changes suggested a possible BDI-II signal, but do not establish efficacy. Supervised SLS met key safety, tolerability, and feasibility criteria, and a lower visual-phenomenology active control can be carried forward, while masking and comparator credibility remain to be established. The next step is a diagnostically defined, CTU-governed Phase 2a feasibility trial that pre-registers a locked protocol and tests masking, credibility, retention and endpoint precision.
]]></description>
<dc:creator><![CDATA[ Nacker, D., Kalus, L., Seth, A. K., Stone, J. M., Lawson, G., Simpson, J., Sander, J. W., bremner, s., Jones, C. I., Wood, W., Macpherson, F., Proeckl, D., Winkler, E., Schwartzman, D. J. ]]></dc:creator>
<dc:date>2026-06-22</dc:date>
<dc:identifier>doi:10.64898/2026.06.17.26355864</dc:identifier>
<dc:title><![CDATA[Stroboscopic Light Stimulation in Adults Reporting Depressive Symptoms: Safety, Tolerability, Feasibility, and Active-Comparator Development in a Staged Early-Phase Study]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory</dc:publisher>
<prism:publicationDate>2026-06-22</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://www.medrxiv.org/content/10.64898/2026.06.16.26355798v1?rss=1">
<title>
<![CDATA[
Rumination as a cognitive vulnerability factor in perinatal bereavement: evidence from the CARING study 
]]>
</title>
<link>
https://www.medrxiv.org/content/10.64898/2026.06.16.26355798v1?rss=1
</link>
<description><![CDATA[
PurposePerinatal loss is associated with a high risk of persistent psychological distress, including prolonged grief, depression, anxiety, and post-traumatic stress symptoms. Cognitive processes such as rumination may play a crucial role in maintaining and amplifying distress following loss, yet their specific contribution in perinatal bereavement remains underexplored.

MethodsThe CARING (Cognitive Analysis and Rumination INvestigation in perinatal Grief) study employed a cross-sectional design involving 298 parents who experienced perinatal loss within the previous five years. Participants completed an anonymous online survey including measures of depressive rumination (Ruminative Response Scale, RRS), angry rumination (Anger Rumination Scale, ARS), perinatal grief (Perinatal Grief Scale, PGS), general psychopathology (SCL-90), and post-traumatic stress symptoms (NSESSS). Non-parametric analyses were conducted to examine associations between rumination patterns and psychological outcomes.

ResultsHigher levels of rumination were significantly associated with greater perinatal grief, depressive and anxiety symptoms, and post-traumatic stress. Depressive rumination showed consistently stronger associations with all outcomes compared to angry rumination. Participants presenting both depressive and angry rumination exhibited the highest levels of grief intensity, psychological distress, and PTSD symptoms, suggesting a graded relationship between rumination patterns and severity of distress. Rumination levels were not significantly associated with gestational age at loss or with having received psychological support.

ConclusionsRumination, particularly in its depressive form, appears to function as a transdiagnostic cognitive vulnerability factor in perinatal bereavement. These findings highlight rumination as a potential target for early screening and tailored psychological interventions aimed at reducing long-term distress following perinatal loss.
]]></description>
<dc:creator><![CDATA[ Ravaldi, C., Mosconi, L., Raduzzi, G., Olmi, C., Neri, I., Cocchi, E., Vannacci, A. ]]></dc:creator>
<dc:date>2026-06-19</dc:date>
<dc:identifier>doi:10.64898/2026.06.16.26355798</dc:identifier>
<dc:title><![CDATA[Rumination as a cognitive vulnerability factor in perinatal bereavement: evidence from the CARING study]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory</dc:publisher>
<prism:publicationDate>2026-06-19</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://www.medrxiv.org/content/10.64898/2026.06.16.26355796v1?rss=1">
<title>
<![CDATA[
Personalizing Suicide Risk Assessment: Machine Learning Extraction of Cross-Modal Interactions Between Psychosocial and Demographic Factors in Veterans 
]]>
</title>
<link>
https://www.medrxiv.org/content/10.64898/2026.06.16.26355796v1?rss=1
</link>
<description><![CDATA[
BackgroundVeterans face an elevated risk of suicide compared to the general population, motivating national efforts to develop predictive models that can guide proactive care. Current models used by the U.S. Department of Veterans Affairs (VA) rely primarily on structured electronic health record (EHR) data, though clinical notes contain rich contextual information that can be quantified using natural language processing (NLP) to derive psychosocial variables that may improve risk detection. Machine learning methods, particularly classification and regression trees (CART), can also uncover interactions between clinical and psychosocial variables, enabling identification of patient characteristics that modify suicide risk factors. However, integrating structured and unstructured data presents challenges because NLP features often greatly outnumber traditional clinical variables, potentially biasing interaction discovery. In prior work, we addressed this imbalance by introducing a weighted CART framework that balances structured variables with NLP-derived psychosocial features from semantic lexicons (SEANCE). While effective, semantic approaches summarize language into predefined constructs and may overlook important lexical variation present in clinical narratives.

MethodsIn this study, we extend that framework by replacing semantic features with a high-dimensional bag-of-words (BoW) representation of clinical notes and by evaluating models across cohorts defined by structured suicide risk stratification (low, medium, high) and varying temporal lookback windows. Using a cohort of 27,241 veterans, we analyzed clinical documentation collected up to 30, 90, or 270 days prior to death (or a matched index date for controls), enabling temporally flexible risk modeling. XGBoost models were trained to balance structured and unstructured features and identify cross-modal interactions between textual and clinical variables.

ResultsWhen incorporated into generalized linear models, these interactions improved predictive performance, particularly among low- and medium-risk patients, and substantially reduced the performance gap between interpretable and more complex models. Notably, the BoW representation outperformed our prior semantic index-based approach.

Discussion and ConclusionsTogether, these findings demonstrate the utility of interpretable NLP methods for uncovering clinically meaningful interactions between psychosocial and demographic factors in suicide risk and establish a strong benchmark for future deep learning approaches aimed at capturing richer contextual and temporal information from clinical narratives.
]]></description>
<dc:creator><![CDATA[ Levis, M. E., Shiner, B., Dimambro, M., Rozema, L., Ayandeh, S., Diallo, A. B., Zhou, Y., Li, S., Wu, W., Gui, J., Levy, J. J. ]]></dc:creator>
<dc:date>2026-06-18</dc:date>
<dc:identifier>doi:10.64898/2026.06.16.26355796</dc:identifier>
<dc:title><![CDATA[Personalizing Suicide Risk Assessment: Machine Learning Extraction of Cross-Modal Interactions Between Psychosocial and Demographic Factors in Veterans]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory</dc:publisher>
<prism:publicationDate>2026-06-18</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://www.medrxiv.org/content/10.64898/2026.06.12.26355405v1?rss=1">
<title>
<![CDATA[
Cardiac rhythm development: A wearable device index of risk for physical and mental illness in adolescence 
]]>
</title>
<link>
https://www.medrxiv.org/content/10.64898/2026.06.12.26355405v1?rss=1
</link>
<description><![CDATA[
ObjectiveThe autonomic nervous system, which regulates cardiac rhythm, undergoes pronounced maturation across adolescence. How cardiac rhythm develops over this period, however, and whether individual differences in its development forecast mental and physical illness, remain open questions. We used three waves of Fitbit data from the Adolescent Brain Cognitive Development (ABCD) Study to characterize the developmental trajectory of the cardiac rhythm and to test whether variation in that trajectory predicts onset of psychopathology and cardiometabolic disease.

Methods8,301 adolescents contributed 242,811 valid Fitbit wear days across Waves 2 (Mage=12), 4 (Mage=14), and 6 (Mage=16). Cosinor mixed-effects models yielded three rhythm parameters per session: mesor (24-hour mean), amplitude (diurnal swing), and acrophase (peak timing). We first characterized age- and sex-specific trajectories, cross-wave stability, and factors shaping the rhythm. We then used parallel-process latent growth models to test whether within-person changes in rhythm tracked symptom trajectories, and hierarchical logistic models to test whether rhythm parameters predicted the first clinical onset of psychopathology and of obesity and hypertension.

ResultsThe cardiac rhythm changed substantially across adolescence: mesor decreased, amplitude flattened, and acrophase shifted later. Within-person change in the rhythm tracked change in blood pressure, BMI, and trajectories of depression and ADHD symptoms. Higher mesor predicted incident onset of all five outcomes controlling for demographics, baseline symptoms, and behavior (ORs 1.36-1.54); amplitude, acrophase, and rhythm instability conferred additional risk.

ConclusionsThe 24-hour cardiac rhythm is a passively measurable substrate of adolescent autonomic development that indexes transdiagnostic risk for psychiatric and cardiometabolic illness.
]]></description>
<dc:creator><![CDATA[ Giampetruzzi, E., Kircanski, K., Pine, D. S., Gotlib, I. H. ]]></dc:creator>
<dc:date>2026-06-18</dc:date>
<dc:identifier>doi:10.64898/2026.06.12.26355405</dc:identifier>
<dc:title><![CDATA[Cardiac rhythm development: A wearable device index of risk for physical and mental illness in adolescence]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory</dc:publisher>
<prism:publicationDate>2026-06-18</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://www.medrxiv.org/content/10.64898/2026.06.16.26355784v1?rss=1">
<title>
<![CDATA[
Empirical Validation and Predictive Utility of the Perinatal Grief Scale in Men after Perinatal Loss 
]]>
</title>
<link>
https://www.medrxiv.org/content/10.64898/2026.06.16.26355784v1?rss=1
</link>
<description><![CDATA[
BackgroundThe Perinatal Grief Scale (PGS) is a widely used instrument for assessing grief following pregnancy loss, yet no study has validated it specifically in men despite documented use in several studies. This gap is critical given fathers persistent underrepresentation in perinatal bereavement research and the absence of empirically supported screening thresholds for this population.

MethodsThis cross-sectional validation study used data from the OPALE project (Observatory on PerinatAL hEalth) conducted by the CiaoLapo Foundation in Italy. Among 276 fathers who experienced stillbirth or miscarriage, we examined criterion validity by testing the association between PGS scores and trauma-related symptomatology assessed via three validated instruments: the Revised Impact of Event Scale (RIES, n=103), National Stressful Events Survey Short Scale (NSESSS, n=95), and SCL-90 (n=173). We systematically tested multiple threshold combinations to identify optimal discriminative performance.

ResultsThe PGS demonstrated excellent criterion validity. The optimal threshold (PGS [&ge;]92) showed sensitivity 81.0%, specificity 81.8%, and Youdens J index 0.628. Fathers scoring [&ge;]92 had 19.12 times the odds of high trauma symptoms (95% CI: 9.35-39.14, p<0.001). ROC analysis yielded AUC=0.829 (95% CI: 0.778-0.880). Associations remained robust across all three trauma instruments in stratified analyses and after adjusting for time since loss, fathers age, living children, and loss type.

ConclusionThis is the first men-specific validation of the PGS, demonstrating strong criterion validity and establishing a clinically meaningful screening threshold ([&ge;]92) for identifying fathers at elevated risk following perinatal loss.
]]></description>
<dc:creator><![CDATA[ Ravaldi, C., Mosconi, L., Nespoli, A., Fumagalli, S., Vannacci, A. ]]></dc:creator>
<dc:date>2026-06-18</dc:date>
<dc:identifier>doi:10.64898/2026.06.16.26355784</dc:identifier>
<dc:title><![CDATA[Empirical Validation and Predictive Utility of the Perinatal Grief Scale in Men after Perinatal Loss]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory</dc:publisher>
<prism:publicationDate>2026-06-18</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://www.medrxiv.org/content/10.64898/2026.06.09.26354804v1?rss=1">
<title>
<![CDATA[
Factor Analysing Predictive Processing: No Evidence for a General Factor Across Tasks 
]]>
</title>
<link>
https://www.medrxiv.org/content/10.64898/2026.06.09.26354804v1?rss=1
</link>
<description><![CDATA[
Background & HypothesisDysfunctional predictive processing (PP), specifically the aberrant weighting of priors, is a frequently-proposed mechanism for psychosis and psychosis-like phenomena (schizotypy). Evidence for this theory mostly originates from single-task studies, which assume that all tasks load onto a single latent construct of PP performance, but the underlying factor structure of PP tasks is unknown. PP deficits in psychosis may be better described by a two-factor, hierarchical model: weakened lower-level (perceptual) priors compensated by higher-level (cognitive) priors.

Study DesignThis study implements a multi-paradigm approach in healthy participants to investigate latent constructs underlying PP and their relationship to schizotypy. Participants (N = 73) completed 6 tasks measuring reliance on priors across language, memory, visual, and auditory domains. A factor analysis investigated whether performance across tasks is captured by a single or two-factor model.

Study ResultsAlthough a two-factor model best described performance, factors reflected within-task correlations rather than a PP hierarchy. Cross-task PP measures were poorly correlated, suggesting that individuals weighting of priors was task-specific. A full model including all task outcomes (not factors) significantly predicted the severity of schizotypal aberrant beliefs but no other schizotypal measures.

ConclusionsThese results do not evidence a single factor underpinning PP performance. It is therefore inappropriate to use results from single tasks to propose a generalised PP deficit in psychosis. Variation was also not captured by a two-factor hierarchical model of priors. Further multi-paradigm research is required to evaluate alternative models or additional variables that describe aberrant PP in psychosis.
]]></description>
<dc:creator><![CDATA[ Miller-Silva, C., Knolle, F., Greve, A., de Beer, F., Mujirishvili, T., MacGregor, L. J., Corlett, P. R., Haarsma, J., Powers, A. R., Murray, G. K. ]]></dc:creator>
<dc:date>2026-06-18</dc:date>
<dc:identifier>doi:10.64898/2026.06.09.26354804</dc:identifier>
<dc:title><![CDATA[Factor Analysing Predictive Processing: No Evidence for a General Factor Across Tasks]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory</dc:publisher>
<prism:publicationDate>2026-06-18</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://www.medrxiv.org/content/10.64898/2026.06.09.26355019v1?rss=1">
<title>
<![CDATA[
The relationship between serotonin transporter occupancy and extracellular serotonin concentration is hyperbolic, not linear: implications for safely tapering antidepressants 
]]>
</title>
<link>
https://www.medrxiv.org/content/10.64898/2026.06.09.26355019v1?rss=1
</link>
<description><![CDATA[
BackgroundHyperbolic tapering is an increasingly recognized approach for discontinuing serotonin reuptake inhibitor (SRI) antidepressants that involves non-linear dose reductions with equal stepwise reductions in serotonin transporter (SERT) occupancy to mitigate withdrawal symptoms. Its theoretical basis is the hyperbolic relationship between SRI dose and SERT occupancy reported in radioligand imaging studies. Hyperbolic tapering implicitly assumes that changes in SERT occupancy approximate changes in biologic effect and withdrawal risk. Because SERT occupancy plateaus across the therapeutic dose range of SRIs, this framework predicts relatively small biologic effects and withdrawal risk within this range. However, SERT occupancy influences serotonergic activity only indirectly via its effects on extracellular serotonin concentrations, and the relationship between these two variables is poorly characterized.

MethodsWe developed a two-pathway clearance model derived from mass-action kinetics to evaluate the steady-state relationship between SERT occupancy and extracellular serotonin concentrations under chronic SRI treatment.

ResultsOur analysis indicates that serotonin concentrations increase hyperbolically as transporter occupancy increases, suggesting that biologically meaningful differences in serotonergic signaling persist across the therapeutic dose range of SRIs despite plateauing occupancy.

ConclusionsOur model predicts a hyperbolic relationship between SERT occupancy and extracellular serotonin concentrations, suggesting that changes in occupancy may not map proportionally onto serotonergic effect. These findings provide a potential mechanistic explanation for dose-dependent clinical effects of SRIs despite plateauing transporter occupancy and generate testable hypotheses regarding antidepressant tapering strategies. Empirical validation is warranted.
]]></description>
<dc:creator><![CDATA[ Cohrs, D., Shapiro, B. ]]></dc:creator>
<dc:date>2026-06-18</dc:date>
<dc:identifier>doi:10.64898/2026.06.09.26355019</dc:identifier>
<dc:title><![CDATA[The relationship between serotonin transporter occupancy and extracellular serotonin concentration is hyperbolic, not linear: implications for safely tapering antidepressants]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory</dc:publisher>
<prism:publicationDate>2026-06-18</prism:publicationDate>
<prism:section></prism:section>
</item>
</rdf:RDF>
